Rothstein, US
Chester Rothstein, Rye, NY US
Patent application number | Description | Published |
---|---|---|
20140265256 | SYSTEMS AND METHODS FOR MOVING PEOPLE - The invention generally relates to people movers fabricated from at least two frame assemblies pivotably connected, for example, in a v formation, wherein the forward end of each frame assembly is pivotably connected such that the rearward end of each frame assembly can be at a variable offset distance so the overall width of the people mover can be adjusted from a maximum (widest) overall width to a minimum (substantially narrow) overall width. Further, the frame assemblies can include forward wheel(s) and/or rearward wheel(s) that can roll in any direction and/or in a regulated range of directions such that when the people mover is at its maximum (widest) width the rearward wheels can only roll in a forward and/or inwardly direction and when the people mover is at its minimum (substantially narrow) width the rearward wheels can only roll in a substantially forward and/or substantially outwardly direction. | 09-18-2014 |
David M. Rothstein, Lexington, MA US
Patent application number | Description | Published |
---|---|---|
20080269185 | Methods Of Treating Oral Mucositis - Methods and kits for treating oral mucositis are disclosed. The treatment comprises administering to a patient in need thereof a Reactive Oxygen Species scavenger in a pharmaceutically acceptable formulation. | 10-30-2008 |
20140343028 | METHODS OF TREATING ORAL MUCOSITIS - Methods and kits for treating oral mucositis are disclosed. The treatment comprises administering to a patient in need thereof a Reactive Oxygen Species scavenger in a pharmaceutically acceptable formulation. | 11-20-2014 |
Dianne M. Rothstein, Ambler, PA US
Patent application number | Description | Published |
---|---|---|
20090005536 | HYBRID SOLID SUPPORTS USEFUL FOR OLIGONUCLEOTIDE PRODUCTION - A method for preparing a crosslinked polymer coated controlled porosity glass (CPG) particle is provided. The method involves mixing CPG particles in a solution comprising polyvinylbenzylchloride and a first solvent at a temperature below 10° C. A second solvent is added and a crosslinking agent is added to the mixture. The first solvent is removed rapidly within 1½ hours of addition of the crosslinking agent. The crosslinking reaction is permitted to proceed and the mixture is then cooled and treated to remove any remaining solvent. The resulting coated CPG particles are washed and dried. Also provided a polymer coated CPG particles using for loading ligand thereon. | 01-01-2009 |
20140087189 | HYBRID SOLID SUPPORTS USEFUL FOR OLIGONUCLEOTIDE PRODUCTION - A method for preparing a crosslinked polymer coated controlled porosity glass (CPG) particle is provided. The method involves mixing CPG particles in a solution comprising polyvinylbenzylchloride and a first solvent at a temperature below 10° C. A second solvent is added and a crosslinking agent is added to the mixture. The first solvent is removed rapidly within 1½ hours of addition of the crosslinking agent. The crosslinking reaction is permitted to proceed and the mixture is then cooled and treated to remove any remaining solvent. The resulting coated CPG particles are washed and dried. Also provided a polymer coated CPG particles using for loading ligand thereon. | 03-27-2014 |
20150133648 | HYBRID SOLID SUPPORTS USEFUL FOR OLIGONUCLEOTIDE PRODUCTION - A method for preparing a crosslinked polymer coated controlled porosity glass (CPG) particle is provided. The method involves mixing CPG particles in a solution comprising polyvinylbenzylchloride and a first solvent at a temperature below 10° C. A second solvent is added and a crosslinking agent is added to the mixture. The first solvent is removed rapidly within hours of addition of the crosslinking agent. The crosslinking reaction is permitted to proceed and the mixture is then cooled and treated to remove any remaining solvent. The resulting coated CPG particles are washed and dried. Also provided a polymer coated CPG particles using for loading ligand thereon. | 05-14-2015 |
Gary Steven Rothstein, Orange Village, OH US
Patent application number | Description | Published |
---|---|---|
20140116126 | TIRE-CONDITION-ASCERTAINING CARTRIDGE - A tire-condition-ascertaining cartridge ( | 05-01-2014 |
Jeff Rothstein, New York, NY US
Patent application number | Description | Published |
---|---|---|
20090127142 | OPTICAL DISC ENCLOSURE INCORPORATING FRAGRANCE ATOMIZER - An enclosure for a disc-shaped medium includes a cover panel integrally formed with a media panel. The panels are delineated by a single or double fold forming a spine. The single or double fold allows the cover panel and the media panel to be opened and closed like a book. A disc holder secures the medium to the media panel. A pocket for a fragrance vial or atomizer, or another item, is formed and secured at inner-facing surfaces of the cover panel, media panel and/or spine. | 05-21-2009 |
Jeffrey Rothstein, Miami Lakes, FL US
Patent application number | Description | Published |
---|---|---|
20100024481 | Method for Producing Layered Rings - A ring formed of a first gold layer and second silver layer wherein the silver layer is more than fifty percent of the ring weight. The layers are bonded together with the gold layer on a portion of the outer surface to give an appearance of a ring formed entirely of gold. A method for fabricating the ring is also provided. | 02-04-2010 |
Jeffrey D. Rothstein, Baltimore, MD US
Patent application number | Description | Published |
---|---|---|
20110201043 | TRANSGENIC MAMMALS AND CELL LINES FOR THE IDENTIFICATION OF GLUTAMATE TRANSPORTER MODULATORS - The invention includes a transgenic, non-human mammal useful for identifying candidate compounds for treating neurological and/or psychiatric disorders. Incorporated into the genome of the transgenic mammal is a transgene comprising a glutamate transporter promoter operatively linked to a reporter gene. The transgenic, non-human mammal and cells isolated therefrom can be used as an in vivo model for the identification of candidate compounds useful for the treatment of neurological and/or psychiatric disorders. | 08-18-2011 |
20120094295 | NEURODEGENERATIVE DISEASE DIAGNOSTIC COMPOSITIONS AND METHODS OF USE - The invention generally provides diagnostics that employ biomarkers altered in neurodegenerative disease, as well as methods for the use of such markers in monitoring disease progression and identifying agents useful for the treatment of a neurodegenerative disease. | 04-19-2012 |
Jeffrey D. Rothstein, Catonsville, MD US
Jesse Abraham Rothstein, Seattle, WA US
Patent application number | Description | Published |
---|---|---|
20080209045 | Capture and Resumption of Network Application Sessions - A system and method for capture and resumption of network application sessions in a network system. A transaction may be detected between a client and server that includes application session state information. The session state information may relate to a session between the client and the server. The Application session state information may be recorded in response to the detection of the transaction, and the application session state information may not be deleted according to session information expiration policies (e.g., of the client). User input may be received which requests to review the captured network application session. Correspondingly, a network request comprising captured credentials of the captured session may be generated and forwarded to the server. The network request may be usable to enable resumption of the captured network application session. | 08-28-2008 |
20080222717 | Detecting Anomalous Network Application Behavior - System and Method for detecting anomalous network application behavior. Network traffic between at least one client and one or more servers may be monitored. The client and the one or more servers may communicate using one or more application protocols. The network traffic may be analyzed at the application-protocol level to determine anomalous network application behavior. Analyzing the network traffic may include determining, for one or more communications involving the client, if the client has previously stored or received an identifier corresponding to the one or more communications. If no such identifier has been observed in a previous communication, then the one or more communications involving the client may be determined to be anomalous. A network monitoring device may perform one or more of the network monitoring, the information extraction, or the information analysis. | 09-11-2008 |
20090141634 | Adaptive Network Traffic Classification Using Historical Context - Adaptive network traffic classification using historical context. Network traffic may be monitored and classified by considering several attributes using packet filters, regular expressions, context-free grammars, rule sets, and/or protocol dissectors, among other means and by applying a variety of techniques such as signature matching and statistical analysis. Unlike static systems, the classification decisions may be reexamined from time to time or after subsequent processing determines that the traffic does not conform to the protocol specification corresponding to the classification decision. Historical context may be used to adjust the classification strategy for similar or related traffic. | 06-04-2009 |
20140269276 | TRIGGER BASED RECORDING OF FLOWS WITH PLAY BACK - The various embodiments provide selective real-time monitoring of one or more flows of packets over a network, real-time buffering of packets for the one or more monitored flows, real-time recording of packets for one or more monitored flows and its corresponding buffered packets based on initiation of at least one trigger, and real-time analysis of the one or more recorded flows of packets regarding at least the occurrence of the at least one trigger. One or more flows of packets may be selected for monitoring by an administrator or an automated process based on different factors. In at least one of the various embodiments, the one or more monitored flows of packets are tagged and threaded so that they are separately accessible in a ring buffer. | 09-18-2014 |
20140269777 | RESYNCHRONIZATION OF PASSIVE MONITORING OF A FLOW BASED ON HOLE DETECTION - Embodiments are directed towards resynchronizing the processing of a monitored flow based on hole detection. A network monitoring device (NMD) may be employed to passively monitor flows of packets for a session between endpoints. The NMD may receive copies of the monitored flow and perform processes on the monitored flow. In some situations, some copies of packets may not be fully processed by the NMD, creating a hole in the processing. If a hole is detected in the monitored flow and the processing of the monitored flow is desynchronized, then the NMD may suspend processing until it is resynchronized or for a remainder of the session. If the processing is desynchronized, then the NMD may resynchronize the processing by resuming the processing of the monitored flow at a downstream position of the monitored flow based on the detected hole. | 09-18-2014 |
20140280907 | AUTOMATED PASSIVE DISCOVERY OF APPLICATIONS - Embodiments are directed to monitoring communication over a network using a network monitoring device (NMD) to discover devices, roles, applications, and application dependencies present on the monitored networks. A NMD may monitor network packets that may be flowing on monitored networks. Using OSI L2-to-L3 data the NMD may determine the devices that may be on the monitored networks. Also, the NMD may determine the network protocols that may be in use on the monitored networks. Further, the NMD may reassemble monitored network packets into transactions based on knowledge regarding the network protocols are in use on the monitored networks. The NMD may perform various tests to determine the applications that may be running on the discovered devices. Some of the tests used by the NMD may examine OSI L4-L7 data that may be included in the transactions. | 09-18-2014 |
20140280908 | DE-DUPLICATING OF PACKETS IN FLOWS AT LAYER 3 - Embodiments are directed towards receiving packets communicated over at least one network, determining layer 3 header information for the received packets, normalizing the determined layer 3 header information for each received packet, employing a determined value based on the normalized layer 3 header information to detect each received packet that is a duplicate, disregarding duplicate packets, and enabling monitoring and analysis of at least selected flows that include packets that are determined to be non-duplicated. Also, if the determined layer 3 header information indicates that the received packet is fragmented, that packet is de-fragmented at least in accordance with a fragment offset. Additionally, normalization may include at least one of masking at least one value in the layer 3 header information, or rolling back changes in the layer 3 header information. | 09-18-2014 |
20150019867 | RESYNCHRONIZATION OF PASSIVE MONITORING OF A FLOW BASED ON HOLE DETECTION - Embodiments are directed towards resynchronizing the processing of a monitored flow based on hole detection. A network monitoring device (NMD) may be employed to passively monitor flows of packets for a session between endpoints. The NMD may receive copies of the monitored flow and perform processes on the monitored flow. In some situations, some copies of packets may not be fully processed by the NMD, creating a hole in the processing. If a hole is detected in the monitored flow and the processing of the monitored flow is desynchronized, then the NMD may suspend processing until it is resynchronized or for a remainder of the session. If the processing is desynchronized, then the NMD may resynchronize the processing by resuming the processing of the monitored flow at a downstream position of the monitored flow based on the detected hole. | 01-15-2015 |
20150036501 | TRIGGER BASED RECORDING OF FLOWS WITH PLAY BACK - The various embodiments provide selective real-time monitoring of one or more flows of packets over a network, real-time buffering of packets for the one or more monitored flows, real-time recording of packets for one or more monitored flows and its corresponding buffered packets based on initiation of at least one trigger, and real-time analysis of the one or more recorded flows of packets regarding at least the occurrence of the at least one trigger. One or more flows of packets may be selected for monitoring by an administrator or an automated process based on different factors. In at least one of the various embodiments, the one or more monitored flows of packets are tagged and threaded so that they are separately accessible in a ring buffer. | 02-05-2015 |
Jonathan P. Rothstein, Belchertown, MA US
Patent application number | Description | Published |
---|---|---|
20100330340 | SUPERHYDROPHOBIC SURFACES FOR DRAG REDUCTION - Superhydrophobic surfaces according to the invention contain micro or nanoscale hydrophobic features which can support a shear-free air-water interface between peaks in the surface topology. The surface of an engineered structure is patterned with a plurality of parallel ridges extending from the surface. The ridges have a width d and a height h, and are spaced apart by a first spacing dimension w. The ridges extend along the surface of the solid object for a predefined length l. Breaker ridges are situated between the parallel ridges, and are oriented at an angle to the parallel ridges. The breaker ridges are preferably spaced apart by a second spacing dimension. The breaker ridges and the parallel ridges are configured to define a volume wherein a gas may be situated. The engineered structure is configured to provide a reduced drag force between itself and a fluid. | 12-30-2010 |
Larry B. Rothstein, Gahanna, OH US
Patent application number | Description | Published |
---|---|---|
20150379656 | METHOD FOR MONITORING THE USE OF CONTROLLED SUBSTANCES - A method for monitoring use of controlled substances by one or more test subjects includes the steps of: entering contact data for a test subject into a monitoring program interacting with appropriate communication hardware to contact the test subject; the said step of entering, the monitoring program thereafter executing the step of: scheduling a random date for a drug test or drug usage test or both for the test subject; the monitoring program thereafter executing the step of attempting to contact the test subject and if successful contact is made, executing the step of advising the test subject as to the random date and, if successful contact is not made, executing the step of recording a failed contact entry and associating the failed contact entry with the test subject. | 12-31-2015 |
Marc L. Rothstein, Ambler, PA US
Patent application number | Description | Published |
---|---|---|
20090005536 | HYBRID SOLID SUPPORTS USEFUL FOR OLIGONUCLEOTIDE PRODUCTION - A method for preparing a crosslinked polymer coated controlled porosity glass (CPG) particle is provided. The method involves mixing CPG particles in a solution comprising polyvinylbenzylchloride and a first solvent at a temperature below 10° C. A second solvent is added and a crosslinking agent is added to the mixture. The first solvent is removed rapidly within 1½ hours of addition of the crosslinking agent. The crosslinking reaction is permitted to proceed and the mixture is then cooled and treated to remove any remaining solvent. The resulting coated CPG particles are washed and dried. Also provided a polymer coated CPG particles using for loading ligand thereon. | 01-01-2009 |
20140087189 | HYBRID SOLID SUPPORTS USEFUL FOR OLIGONUCLEOTIDE PRODUCTION - A method for preparing a crosslinked polymer coated controlled porosity glass (CPG) particle is provided. The method involves mixing CPG particles in a solution comprising polyvinylbenzylchloride and a first solvent at a temperature below 10° C. A second solvent is added and a crosslinking agent is added to the mixture. The first solvent is removed rapidly within 1½ hours of addition of the crosslinking agent. The crosslinking reaction is permitted to proceed and the mixture is then cooled and treated to remove any remaining solvent. The resulting coated CPG particles are washed and dried. Also provided a polymer coated CPG particles using for loading ligand thereon. | 03-27-2014 |
20150133648 | HYBRID SOLID SUPPORTS USEFUL FOR OLIGONUCLEOTIDE PRODUCTION - A method for preparing a crosslinked polymer coated controlled porosity glass (CPG) particle is provided. The method involves mixing CPG particles in a solution comprising polyvinylbenzylchloride and a first solvent at a temperature below 10° C. A second solvent is added and a crosslinking agent is added to the mixture. The first solvent is removed rapidly within hours of addition of the crosslinking agent. The crosslinking reaction is permitted to proceed and the mixture is then cooled and treated to remove any remaining solvent. The resulting coated CPG particles are washed and dried. Also provided a polymer coated CPG particles using for loading ligand thereon. | 05-14-2015 |
Michael J. Rothstein, Bohemia, NY US
Patent application number | Description | Published |
---|---|---|
20120092609 | EYEWEAR ASSEMBLY - The present invention provides an eyewear assembly including a frame having a first portion and a second portion defining a first lens aperture for receiving a lens. The first portion is displaceable from the second portion to change the size of the lens aperture. The first frame portion includes a first arm extending therefrom and the second frame portion includes a second arm extending therefrom. The first and second arms include a connecting device disposed therebetween for restricting relative movement between the first and second arms. A securement body includes a slot for receiving therein the first and second arms. A locking member is engageable with the securement body and at least one of the first and second arms to secure the frame to the securement body. | 04-19-2012 |
Michelle B. Rothstein, Gahanna, OH US
Patent application number | Description | Published |
---|---|---|
20150379656 | METHOD FOR MONITORING THE USE OF CONTROLLED SUBSTANCES - A method for monitoring use of controlled substances by one or more test subjects includes the steps of: entering contact data for a test subject into a monitoring program interacting with appropriate communication hardware to contact the test subject; the said step of entering, the monitoring program thereafter executing the step of: scheduling a random date for a drug test or drug usage test or both for the test subject; the monitoring program thereafter executing the step of attempting to contact the test subject and if successful contact is made, executing the step of advising the test subject as to the random date and, if successful contact is not made, executing the step of recording a failed contact entry and associating the failed contact entry with the test subject. | 12-31-2015 |
Polly Rothstein, Purchase, NY US
Patent application number | Description | Published |
---|---|---|
20140265256 | SYSTEMS AND METHODS FOR MOVING PEOPLE - The invention generally relates to people movers fabricated from at least two frame assemblies pivotably connected, for example, in a v formation, wherein the forward end of each frame assembly is pivotably connected such that the rearward end of each frame assembly can be at a variable offset distance so the overall width of the people mover can be adjusted from a maximum (widest) overall width to a minimum (substantially narrow) overall width. Further, the frame assemblies can include forward wheel(s) and/or rearward wheel(s) that can roll in any direction and/or in a regulated range of directions such that when the people mover is at its maximum (widest) width the rearward wheels can only roll in a forward and/or inwardly direction and when the people mover is at its minimum (substantially narrow) width the rearward wheels can only roll in a substantially forward and/or substantially outwardly direction. | 09-18-2014 |
Richard Rothstein, Etna, NH US
Patent application number | Description | Published |
---|---|---|
20120165829 | MEDICAL DEVICE CONTROL SYSTEM - A control system for allowing a user to control the orientation of a medical device or a medical instrument in a variety of directions. An actuator selectively tensions one or more control cables having ends secured at or adjacent a distal tip of the medical device in order to bend the distal tip in a desired direction. In one embodiment, a physician can adjust the movement of the distal tip in a desired direction without affecting the orientation of the medical device in other directions. | 06-28-2012 |
20150282788 | MEDICAL DEVICE CONTROL SYSTEM - A control system for allowing a user to control the orientation of a medical device or a medical instrument in a variety of directions. An actuator selectively tensions one or more control cables having ends secured at or adjacent a distal tip of the medical device in order to bend the distal tip in a desired direction. In one embodiment, a physician can adjust the movement of the distal tip in a desired direction without affecting the orientation of the medical device in other directions. | 10-08-2015 |
Richard I. Rothstein, Etna, NH US
Patent application number | Description | Published |
---|---|---|
20090281559 | ANASTOMOSIS PATCH - An apparatus, system, and method for covering an anastomosis are disclosed. The apparatus includes a resilient flexible patch having a diameter that is greater than the diameter of an anastomosis. A opening is formed in the patch. The opening has a diameter that is less than the diameter of the anastomosis. The system further includes a joining element to attach the patch to tissue adjacent to the anastomosis. At least one hole is formed around the perimeter of the patch. The at least one hole is to receive the joining element therethrough. The method includes inserting a resilient flexible patch having a diameter that is greater than the diameter of an anastomosis through a working channel of an endoscope, locating the patch adjacent to the anastomosis, and attaching the patch to tissue adjacent to the anastomosis using a joining element. | 11-12-2009 |
Rodney J. Rothstein, Maplewood, NJ US
Patent application number | Description | Published |
---|---|---|
20140154340 | METHODS TO TREAT CANCER USING CYCLOSPORINE AND CYCLOSPORINE DERIVATIVES - Methods to treat certain types of cancer with cyclophilin inhibitors. | 06-05-2014 |
Russell I. Rothstein, Potomac, MD US
Patent application number | Description | Published |
---|---|---|
20080250057 | Data Table Management System and Methods Useful Therefor - A data table management system operative to manage at least one data table storing a multiplicity of data elements such as data records, the system comprising a data element usage monitor operative to record information pertaining to usage of individual elements in at least one data table; and a data element evaluator operative to evaluate the importance of data elements as a function of the information pertaining to usage thereof recorded by the data element usage monitor. The system and methods are described in the context of a relational data base and a RDBMS data warehouse merely by way of example. The systems and methods described including those pertaining to fine-grained monitoring and usage-based analysis are also applicable to other structured data management systems such as but not limited to as object-oriented databases including XML-oriented databases and distributed systems based on the XQuery framework. | 10-09-2008 |
Sam Rothstein, Pittsburg, PA US
Patent application number | Description | Published |
---|---|---|
20120172456 | ENGINEERED MICROPARTICLES FOR MACROMOLECULE DELIVERY - A method for making a modified release composition, comprising: | 07-05-2012 |